Olema Pharmaceuticals (OLMA) Change in Account Payables (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Change in Account Payables data on file, last reported at -$5.7 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 31.84% year-over-year to -$5.7 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 147.74% increase from a year earlier, with the FY2025 full-year figure at $4.6 million, up 83.19% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$5.7 million, down from $5.8 million in the prior quarter.
• Over the last five years, Change in Account Payables for OLMA reached as high as $5.8 million in Q4 2025 and fell as low as -$5.7 million in Q1 2026.
• Historically, Change in Account Payables has averaged $241294.1 across 5 years, with a median of $360000.0 in 2022.
• Across the five-year window, Change in Account Payables plunged 3060.0% in 2022 and jumped 1514.98% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at $360000.0 in 2022, then jumped by 36.39% to $491000.0 in 2023, then soared by 413.85% to $2.5 million in 2024, then surged by 128.81% to $5.8 million in 2025, then tumbled by 198.41% to -$5.7 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$5.7 million in Q1 2026, $5.8 million in Q4 2025, and $2.4 million in Q3 2025.